These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37971267)

  • 1. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.
    Kinloch NN; Shahid A; Dong W; Kirkby D; Jones BR; Beelen CJ; MacMillan D; Lee GQ; Mota TM; Sudderuddin H; Barad E; Harris M; Brumme CJ; Jones RB; Brockman MA; Joy JB; Brumme ZL
    mBio; 2023 Dec; 14(6):e0241723. PubMed ID: 37971267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
    Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
    J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.
    Kinloch NN; Shahid A; Dong W; Kirkby D; Jones BR; Beelen CJ; MacMillan D; Lee GQ; Mota TM; Sudderuddin H; Barad E; Harris M; Brumme CJ; Jones RB; Brockman MA; Joy JB; Brumme ZL
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
    Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
    mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
    Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
    Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobamibias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL
    Res Sq; 2023 Aug; ():. PubMed ID: 37645749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence Evaluation and Comparative Analysis of Novel Assays for Intact Proviral HIV-1 DNA.
    Gaebler C; Falcinelli SD; Stoffel E; Read J; Murtagh R; Oliveira TY; Ramos V; Lorenzi JCC; Kirchherr J; James KS; Allard B; Baker C; Kuruc JD; Caskey M; Archin NM; Siliciano RF; Margolis DM; Nussenzweig MC
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
    Patro SC; Niyongabo A; Maldarelli F; Kearney MF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
    J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
    Wang X; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
    Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing.
    Cho A; Gaebler C; Olveira T; Ramos V; Saad M; Lorenzi JCC; Gazumyan A; Moir S; Caskey M; Chun TW; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Genomes Are Enriched in Memory CD4
    Morcilla V; Bacchus-Souffan C; Fisher K; Horsburgh BA; Hiener B; Wang XQ; Schlub TE; Fitch M; Hoh R; Hecht FM; Martin JN; Deeks SG; Hellerstein MK; McCune JM; Hunt PW; Palmer S
    mBio; 2021 Oct; 12(5):e0244721. PubMed ID: 34544282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy.
    Sun W; Rassadkina Y; Gao C; Collens SI; Lian X; Solomon IH; Mukerji SS; Yu XG; Lichterfeld M
    Elife; 2023 Nov; 12():. PubMed ID: 37938115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective proviruses rapidly accumulate during acute HIV-1 infection.
    Bruner KM; Murray AJ; Pollack RA; Soliman MG; Laskey SB; Capoferri AA; Lai J; Strain MC; Lada SM; Hoh R; Ho YC; Richman DD; Deeks SG; Siliciano JD; Siliciano RF
    Nat Med; 2016 Sep; 22(9):1043-9. PubMed ID: 27500724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
    Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
    Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
    Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
    J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies.
    Kreider EF; Bar KJ
    Curr HIV/AIDS Rep; 2022 Jun; 19(3):194-206. PubMed ID: 35404007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
    Nicolas A; Migraine J; Dutrieux J; Salmona M; Tauzin A; Hachiya A; Estaquier J; Molina JM; Clavel F; Hance AJ; Mammano F
    Microbiol Spectr; 2022 Aug; 10(4):e0078422. PubMed ID: 35770985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.